Literature DB >> 3964558

Transient activation of the acetyltransferase necessary for paf-acether biosynthesis in thrombin-activated platelets.

E Coëffier, E Ninio, J P Le Couedic, M Chignard.   

Abstract

Thrombin-activated platelets formed paf-acether (1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine), a molecule susceptible to play a role in haemostasis and thrombosis, and its deacetylated analogue, lyso paf-acether, a biologically inactive molecule. We presently show the presence in human and rabbit platelet lysates of an acetyltransferase which transfers the acetyl moiety of acetyl-coenzyme A (acetyl-CoA) onto synthetic lyso paf-acether, yielding the fully active paf-acether molecule. Under our optimal standard conditions, 0.36 +/- 0.23 nmol paf-acether/10 min/mg proteins was formed by the acetyltransferase from resting human platelets. Upon thrombin stimulation, the acetyltransferase activity doubled within 30 s, reaching a maximum at 2 min (1.17 +/- 0.31 nmol paf-acether/10 min/mg proteins) and decreased progressively. Similar results were obtained using rabbit platelets. In addition we demonstrated that the activation and deactivation of the acetyltransferase correlated with the kinetics of paf-acether formation by thrombin-activated rabbit platelets. It is hypothesized that this enzyme may represent one of the regulating mechanism of paf-acether formation by platelets.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964558     DOI: 10.1111/j.1365-2141.1986.tb04087.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 2.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

3.  Synthesis of a PAF immunogen and production of PAF-specific antibodies.

Authors:  M A Smal; B A Baldo; J W Redmond
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Studies on the selectivity of enzymes involved in platelet-activating factor formation in stimulated cells.

Authors:  H van den Bosch; A Sturk; J W ten Cate; A J Aarsman
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

5.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

6.  Human platelets effectively kill K-562 cells, a chronic myelogenic leukemia cell line, in vitro.

Authors:  T Sagawa; T Kodama; A Tominaga; M Okada
Journal:  Jpn J Cancer Res       Date:  1990-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.